Long-term protection in at-risk hypertensive patients - A role for nifedipine GITS?

Blood Pressure

Volumn 11, Issue 2, 2002, Pages 106-109

  Ruilope, Luis M ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Atherosclerosis; Co amilozide; Hypertension; INSIGHT; Nifedipine

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; ISRADAPINE; LISINOPRIL; LOSARTAN; NIFEDIPINE; NISOLDIPINE; NITRENDIPINE; PLACEBO; UNCLASSIFIED DRUG; AMILORIDE; CO-AMILOZIDE; HYDROCHLOROTHIAZIDE;

ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; DISEASE COURSE; DRUG EFFICACY; DRUG FORMULATION; EVIDENCE BASED MEDICINE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LONG TERM CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ARTERIOSCLEROSIS; DRUG COMBINATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

AMILORIDE; ARTERIOSCLEROSIS; CALCIUM CHANNEL BLOCKERS; CARDIOVASCULAR DISEASES; DIURETICS; DRUG COMBINATIONS; HUMAN; HYDROCHLOROTHIAZIDE; HYPERTENSION; NIFEDIPINE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; HUMANS;

EID: 0035988512     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/08037050211264     Document Type: Article

References (21)

1. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
3. Diabetes and cardiovascular events in hypertensive patients
4. Differential effects of nifedipine and co-amilozide on the progression of early carotid wall changes
5. Calcium channel blocker nifedipine slows down progression of coronary calcification in hypertensive patients compared with diuretics
6. The role of carotid arterial intima-media thickness in predicting clinical coronary events
7. Excessive mural calcium overload - A predominant causal factor in the development of stenosing coronary plaques in humans
8. Atherogenesis, calcium and calcium antagonists
9. Retardation of angiographic progression of coronary artery disease by nifedipine. Results of the International Nifedipine Trial on Antiatherosclerotic Therapy (INTACT)
10. Design and current status of ACTION: A Coronary disease Trial Investigating Outcome with Nifedipine GITS. Gastro-Intestinal Therapeutic System
11. Randomized trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
12. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: The Nordic Diltiazem (NORDIL) study
13. Randomized double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
14. Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients: Results from the Swedish Trial in Old Patients with Hypertension-2
15. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators
16. British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity
17. Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
18. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
19. Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial
20. Calcium channel blockers in diabetic subjects: Innocent at last?
21. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy